Journal of Neuroimmunology
Volume 221, Issue 1 , Pages 81-86, 15 April 2010

The antibody response to oligodendrocyte specific protein in multiple sclerosis

Department of Neurology, Technische Universität München, Klinikum rechts der Isar, 81675 München, Germany

Received 18 November 2009; received in revised form 7 February 2010; accepted 9 February 2010. published online 18 March 2010.

Abstract 

The role of autoantibody responses in pathogenesis or progression of multiple sclerosis (MS) remains controversial. This is partly because the methods that can distinctly identify pathogenic antibody reactivities targeting native membrane proteins from the reactivities that originate as an epiphenomenon in such disease are just emerging. Oligodendrocyte specific protein (OSP or claudin-11) is a candidate autoantigen in MS and CSF reactivity towards OSP has been reported in MS patients. We characterized the autoantibody response to OSP using sensitive cell based assays. In line with a previous report, higher antibody response to OSP 114–120 peptide and denatured protein was observed. However applying assays based on native OSP we did not observe any specific OSP response in MS patients. Our results demonstrate that anti-OSP antibodies do not recognise native glial OSP and may therefore rather represent an epiphenomenon in MS.

Keywords: Oligodendrocyte specific protein, Multiple sclerosis, Autoantibody response

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0165-5728(10)00057-3

doi:10.1016/j.jneuroim.2010.02.008

Journal of Neuroimmunology
Volume 221, Issue 1 , Pages 81-86, 15 April 2010